JP2011527299A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527299A5
JP2011527299A5 JP2011517026A JP2011517026A JP2011527299A5 JP 2011527299 A5 JP2011527299 A5 JP 2011527299A5 JP 2011517026 A JP2011517026 A JP 2011517026A JP 2011517026 A JP2011517026 A JP 2011517026A JP 2011527299 A5 JP2011527299 A5 JP 2011527299A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
inhibiting
hcv
hcv replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011517026A
Other languages
English (en)
Japanese (ja)
Other versions
JP5426671B2 (ja
JP2011527299A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/004942 external-priority patent/WO2010003658A1/en
Publication of JP2011527299A publication Critical patent/JP2011527299A/ja
Publication of JP2011527299A5 publication Critical patent/JP2011527299A5/ja
Application granted granted Critical
Publication of JP5426671B2 publication Critical patent/JP5426671B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011517026A 2008-07-08 2009-07-08 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体 Expired - Fee Related JP5426671B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP08159965.6 2008-07-08
EP08159965 2008-07-08
EP08160254 2008-07-11
EP08160254.2 2008-07-11
EP08161743.3 2008-08-04
EP08161743 2008-08-04
PCT/EP2009/004942 WO2010003658A1 (en) 2008-07-08 2009-07-08 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013176771A Division JP5808370B2 (ja) 2008-07-08 2013-08-28 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体

Publications (3)

Publication Number Publication Date
JP2011527299A JP2011527299A (ja) 2011-10-27
JP2011527299A5 true JP2011527299A5 (enExample) 2013-10-17
JP5426671B2 JP5426671B2 (ja) 2014-02-26

Family

ID=40972916

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011517026A Expired - Fee Related JP5426671B2 (ja) 2008-07-08 2009-07-08 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体
JP2013176771A Active JP5808370B2 (ja) 2008-07-08 2013-08-28 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013176771A Active JP5808370B2 (ja) 2008-07-08 2013-08-28 Ｃ型肝炎ウイルス阻害剤として有用な大環状インドール誘導体

Country Status (31)

Country Link
US (2) US8921355B2 (enExample)
EP (1) EP2310396B1 (enExample)
JP (2) JP5426671B2 (enExample)
KR (1) KR101640374B1 (enExample)
CN (1) CN102089314B (enExample)
AP (1) AP2743A (enExample)
AR (1) AR072726A1 (enExample)
AU (1) AU2009267389B8 (enExample)
BR (1) BRPI0915887B8 (enExample)
CA (1) CA2729307C (enExample)
CL (1) CL2011000032A1 (enExample)
CO (1) CO6351793A2 (enExample)
CR (1) CR20110076A (enExample)
DK (1) DK2310396T3 (enExample)
EA (1) EA019008B1 (enExample)
EC (1) ECSP11010750A (enExample)
ES (1) ES2651038T3 (enExample)
HN (1) HN2011000072A (enExample)
HR (1) HRP20171892T1 (enExample)
HU (1) HUE035244T2 (enExample)
IL (1) IL210086A (enExample)
LT (1) LT2310396T (enExample)
MX (1) MX2011000276A (enExample)
NI (1) NI201100010A (enExample)
NO (1) NO2310396T3 (enExample)
NZ (2) NZ603343A (enExample)
SI (1) SI2310396T1 (enExample)
SV (1) SV2011003796A (enExample)
TW (1) TWI454476B (enExample)
UY (1) UY31973A (enExample)
WO (1) WO2010003658A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8524716B2 (en) 2007-12-24 2013-09-03 Janssen R&D Ireland Macrocyclic indoles as hepatitis C virus inhibitors
TWI454476B (zh) * 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
UA108211C2 (uk) * 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
NZ602552A (en) * 2010-04-13 2014-09-26 Janssen Pharmaceuticals Inc Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside
WO2011161232A1 (en) 2010-06-24 2011-12-29 Tibotec Pharmaceuticals PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2-{2-[METHYL-(SULPHAMOYL)-AMINO]-ETHOXY}-ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID
EP2760821B1 (en) 2011-09-02 2017-10-11 Novartis AG Choline salt of an anti-inflammatory substituted cyclobutenedione compound
US8716275B2 (en) * 2011-10-20 2014-05-06 Bristol-Myers Squibb Company Compound for the treatment of hepatitis C
KR20150046083A (ko) 2012-08-31 2015-04-29 얀센 파마슈티칼즈, 인코포레이티드 Ｈｃｖ의 거대환형 프로테아제 저해제, 비­뉴클레오시드계 ｈｃｖ 저해제 및 리토나비르의 조합물
WO2014152275A1 (en) * 2013-03-14 2014-09-25 Concert Pharmaceuticals, Inc. Deuterium modified derivatives of the ns5b polymerase inhibitor tmc647055
US10450263B2 (en) 2017-02-10 2019-10-22 Southern Research Institute Benzo annulenes as antiviral agents
KR101974388B1 (ko) 2017-06-23 2019-05-02 (주)에니켐텍 알킬 디에틸렌 트리아민 유도체 및 이의 제조방법
US11066357B2 (en) 2017-12-26 2021-07-20 Southern Research Institute Benzoannulene derivatives as antiviral agents
US12274700B1 (en) 2020-10-30 2025-04-15 Accencio LLC Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors
US12060148B2 (en) 2022-08-16 2024-08-13 Honeywell International Inc. Ground resonance detection and warning system and method
CN116425782A (zh) * 2023-03-22 2023-07-14 烟台盛凯伦化学科技有限公司 一种5-乙酰基-2-氟苯硼酸频哪醇酯的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US5807876A (en) 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
US6054472A (en) 1996-04-23 2000-04-25 Vertex Pharmaceuticals, Incorporated Inhibitors of IMPDH enzyme
US20050267836A1 (en) * 1996-03-25 2005-12-01 Cfph, Llc Method and system for transacting with a trading application
CZ298463B6 (cs) 1996-04-23 2007-10-10 Vertex Pharmaceuticals Incorporated Deriváty mocoviny pro použití jako inhibitory IMPDH enzymu a farmaceutické prostredky, které je obsahují
AU6701598A (en) 1997-03-14 1998-09-29 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
SK13332001A3 (sk) 1999-03-19 2002-02-05 Vertex Pharmaceuticals Incorporated Inhibítory IMPDH enzýmu a ich použitie
US6891331B2 (en) 2000-08-30 2005-05-10 Matsushita Electric Industrial Co., Ltd. Plasma display unit and production method thereof
KR20120090077A (ko) 2004-01-30 2012-08-16 얀센 알 앤드 디 아일랜드 Ｈｃｖ ｎｓ?３ 세린 프로테아제 저해제
US7153848B2 (en) 2004-08-09 2006-12-26 Bristol-Myers Squibb Company Inhibitors of HCV replication
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
RU2008112661A (ru) 2005-09-02 2009-10-10 Тиботек Фармасьютикалз Лтд. (Ie) Бензодиазепины в качестве ингибиторов hcv
US7399758B2 (en) 2005-09-12 2008-07-15 Meanwell Nicholas A Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
GB0522881D0 (en) 2005-11-10 2005-12-21 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2007092000A1 (en) 2006-02-06 2007-08-16 Bristol-Myers Squibb Company Inhibitors of hcv replication
US7521443B2 (en) * 2006-05-17 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7456166B2 (en) 2006-05-17 2008-11-25 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
US7521441B2 (en) 2006-05-22 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
WO2007140200A2 (en) * 2006-05-25 2007-12-06 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
MX2009003452A (es) 2006-10-10 2009-04-14 Medivir Ab Inhibidores nucleosidicos del vhc.
CA2672250C (en) * 2006-12-20 2013-04-30 Ian Stansfield Antiviral indoles
JP2010533699A (ja) * 2007-07-17 2010-10-28 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー Ｃ型肝炎感染症の治療のための大環状インドール誘導体
TWI454476B (zh) 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
TW201023858A (en) 2008-09-18 2010-07-01 Ortho Mcneil Janssen Pharm Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside
MX340792B (es) 2009-02-27 2016-07-25 Ortho-Mcneil-Janssen Pharmaceuticals Inc * Sal amorfa de un inhibidor macrociclico de virus de hepatitis c.
NZ602552A (en) 2010-04-13 2014-09-26 Janssen Pharmaceuticals Inc Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside
WO2011161232A1 (en) 2010-06-24 2011-12-29 Tibotec Pharmaceuticals PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2-{2-[METHYL-(SULPHAMOYL)-AMINO]-ETHOXY}-ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID
KR20150046083A (ko) 2012-08-31 2015-04-29 얀센 파마슈티칼즈, 인코포레이티드 Ｈｃｖ의 거대환형 프로테아제 저해제, 비­뉴클레오시드계 ｈｃｖ 저해제 및 리토나비르의 조합물

Similar Documents

Publication Publication Date Title
JP2013518107A5 (enExample)
JP2013509429A5 (enExample)
JP2009545527A5 (enExample)
JP2011518833A5 (enExample)
JP2015078230A5 (enExample)
JP2011105738A5 (enExample)
JP2013014622A5 (enExample)
JP2010077141A5 (enExample)
JP2013525444A5 (enExample)
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
JP2013542247A5 (enExample)
JP2012255026A5 (enExample)
JP2013032389A5 (enExample)
JP2013507423A5 (enExample)
JP2009535462A5 (enExample)
JP2016503793A5 (enExample)
HRP20150725T1 (hr) Kondenzirani imidazolilimidazoli kao antivirusni spojevi
JP2016515561A5 (enExample)
HRP20171175T1 (hr) Novi triciklički spojevi
JP2016518337A5 (enExample)
JP2011528713A5 (enExample)
EA200802444A1 (ru) Стабилизированные фармацевтические композиции, содержащие фезотеродин
JP2014500861A5 (enExample)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2017513917A5 (enExample)